Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.
Related Posts
The Shipbreakers | 60 Minutes Archive
In 2006, Bob Simon traveled to Bangladesh, where thousands of low-paid workers — including children — were dismantling old ships…
Sly Stone, frontman of Sly and the Family Stone, dies at 82
Sly Stone, the musician known for his own brand of funk with Sly and the Family Stone, has died at…
1/28: CBS Evening News
ICE gears up for immigration raids in New York City; China’s DeepSeek takes U.S. tech by surprise